Hepatitis B screening

Revision as of 21:30, 10 February 2012 by Varun Kumar (talk | contribs)
Jump to navigation Jump to search

Hepatitis Main Page

Hepatitis B

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Hepatitis B from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hepatitis B screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatitis B screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatitis B screening

CDC on Hepatitis B screening

Hepatitis B screening in the news

Blogs on Hepatitis B screening

Directions to Hospitals Treating Hepatitis B

Risk calculators and risk factors for Hepatitis B screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

American Association for the Study of Liver Diseases(ASSLD) 2009 Guidelines for Chronic Hepatitis B[1]

The following groups should be tested for HBV

infection:

  • persons born in high or intermediate endemic areas,
  • United States– born persons not vaccinated as infants whose parents were born in regions with high HBV endemicity,
  • persons with chronically elevated aminotransferases,
  • persons needing immunosuppressive therapy
  • men who have sex with men
  • persons with multiple sexual partners or history of sexually transmitted disease,
  • inmates of correctional facilities,
  • persons who have ever used injecting drugs, dialysis patients, HIV or HCV-infected individuals, pregnant women, and family members, household members, and sexual contacts of HBV-infected persons.
  • Testing for HBsAg and anti-HBs should be performed, and seronegative persons should be vaccinated. (Grade I Recommendation)

References

  1. Lok AS, McMahon BJ (2004). "[AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines]" (PDF). Romanian Journal of Gastroenterology. 13 (2): 150–4. PMID 15229781. Retrieved 2012-02-10. Unknown parameter |month= ignored (help)

Template:WH Template:WS